Gilead’s Twice-Annual Sunlenca Posts Zero Infection Rate In PrEP Trial

 
• By Joseph Haas
  
HIV prep
Gilead is working to add a twice-annual injectable option for HIV PrEP • Source: Shutterstock

More from Clinical Trials

More from R&D